Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomes - Commentary

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
JournalAnnals of Internal Medicine
Volume152
Issue number6
StatePublished - Mar 16 2010

Fingerprint

tibolone
Tamoxifen
Breast Neoplasms
Raloxifene Hydrochloride

ASJC Scopus subject areas

  • Internal Medicine

Cite this

@article{3be0b2b40dc841f1b4fadecae5020885,
title = "Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomes - Commentary",
author = "Joy Melnikow",
year = "2010",
month = "3",
day = "16",
language = "English (US)",
volume = "152",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "6",

}

TY - JOUR

T1 - Review

T2 - Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomes - Commentary

AU - Melnikow, Joy

PY - 2010/3/16

Y1 - 2010/3/16

UR - http://www.scopus.com/inward/record.url?scp=77952560199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952560199&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77952560199

VL - 152

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 6

ER -